OSE Immunotherapeutics’ €18.6 Million Private Placement

Jones Day advised Bank Degroof Petercam SA/NV and Invest Securities SA on the deal. OSE Immunotherapeutics S.A., an integrated biotechnology company developing innovative immunotherapies, directly or…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Paolo Bossi

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here